| 000 -LEADER |
|---|
| fixed length control field |
03020cam a2200457 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
17922493 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
NUST |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20191003131217.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
131028s2014 nyua b 001 0deng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2013042849 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781610392525 (hardcover) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| Canceled/invalid ISBN |
9781610392532 (e-book) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(DNLM)101618829 |
| 038 ## - RECORD CONTENT LICENSOR |
|---|
| Staff Name |
waseem |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Description conventions |
rda |
| Modifying agency |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS431.A64 |
| Item number |
M37 2014 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QZ 11.1 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.994061 |
| Author Mark |
MAR |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Marks, Paul A., |
| Relator term |
author. |
| 9 (RLIN) |
22714 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
On the cancer frontier : |
| Remainder of title |
one man, one disease, and a medical revolution / |
| Statement of responsibility, etc. |
Paul A. Marks, MD and James Sterngold. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
First edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
PublicAffairs, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2014] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xiv, 251 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
22 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Paul Marks M.D., President Emeritus of Memorial Sloan-Kettering Cancer Hospital, attributes the elusive nature of cancers cure to its inherently anarchic processes. There can be no hope for a miracle cure when defective cells use a myriad of tools to succeed in their relentless assaults. There are many ways cancers get started, and turn healthy cell division and growth into lethal attacks. Cancer cells and their abnormal genes are inherently unstable and so, are able to fight off anything that gets in their way-often a prescribed drug. In 1950 the discovery of cancer was all but a death sentence. By 1980, 214 of every 100,000 Americans died from cancer. As late as 1986, an article in the New England Journal of Medicine revealed the less-than-optimistic outlook cancer research, publishing the condemning sentence : we are losing the war against cancer." In fact, though cancer had not been eliminated, it had begun to be identified for what it is. A highly individualistic disease, variable-a guerrilla cell rather than a marching army. Suddenly science learned how to fight the right war-at ever closer quarters. And at the forefront of the momentous chain of discoveries was Paul Marks. Chronicling the insights of researchers and doctors around the world and the momentous effects of their pains-taking advances- Marks weaves together the humbling account of how and what we learned about the mechanisms of malignant and abnormal cells that make up every one of us"--Provided by publisher. |
| 600 12 - SUBJECT ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Marks, Paul A. |
| 9 (RLIN) |
22715 |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Neoplasms |
| General subdivision |
history. |
| 9 (RLIN) |
22716 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Antineoplastic Agents |
| General subdivision |
history. |
| 9 (RLIN) |
22717 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Biomedical Research. |
| 9 (RLIN) |
22718 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Cell Transformation, Neoplastic. |
| 9 (RLIN) |
22719 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Medical Oncology |
| General subdivision |
history. |
| 9 (RLIN) |
22720 |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Neoplasms |
| General subdivision |
therapy. |
| 9 (RLIN) |
22721 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sterngold, James, |
| Relator term |
author. |
| 9 (RLIN) |
22722 |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ecip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Book |
